Validation of histological diagnostic methods for detecting endothelin B receptor expression

Fukuda,Naoya; Tsuchikawa,Takahiro; Fukunaga,Akira; Kawase,Hiroshi; Homma,Naotake; Nakamura,Toru; Shichinohe,Toshiaki; Hirano,Satoshi

doi:10.3892/or.2014.3031

Validation of histological diagnostic methods for detecting endothelin B receptor expression

Authors:
- Naoya Fukuda
- Takahiro Tsuchikawa
- Akira Fukunaga
- Hiroshi Kawase
- Naotake Homma
- Toru Nakamura
- Toshiaki Shichinohe
- Satoshi Hirano
View Affiliations

Affiliations: Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Published online on: February 19, 2014 https://doi.org/10.3892/or.2014.3031
Pages: 1561-1566

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis. Recently, it was reported that the endothelin B receptor (ETBR) of tumor endothelial cells prevents antitumor immunity. However, the immunohistochemistry (IHC) conditions required to detect ETBR expression remain unclear. The aim of the present study was to confirm the appropriate conditions for IHC for ETBR using ETBR cDNA and transfectant cells and to assess ETBR expression in PDAC patients. An ETBR-expressing cell was established as an objective positive control and the detectability of ETBR expression was evaluated using several types of anti-ETBR antibodies. ETBR mRNA expression was then studied. Finally, ETBR expression was examined in human PDAC tissue using IHC. As a result, four different anti-ETBR antibodies recognized the cell surface ETBR appropriately. A non-specific reaction was shown in the detection of ETBR in normal human tissues. ETBR mRNA expression was weakly detected only in the adrenal gland. No biologically significant correlation was observed in the ETBR-IHC of human PDAC sections. In conclusion, it is necessary to perform IHC using an appropriate control to assess the tissue expression of ETBR.

View Figures

View References

1	Hidalgo M: Pancreatic cancer. N Engl J Med. 362:1605–1617. 2010. View Article : Google Scholar
2	Vincent A, Herman J, Schulick R, Hruban RH and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011. View Article : Google Scholar
3	Fukunaga A, Miyamoto M, Cho Y, et al: CD8⁺ tumor-infiltrating lymphocytes together with CD4⁺ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas. 28:e26–e31. 2004.
4	Uehara H, Miyamoto M, Kato K, et al: Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res. 64:3533–3537. 2004. View Article : Google Scholar
5	Sakurai T, Yanagisawa M, Takuwa Y, et al: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:732–735. 1990. View Article : Google Scholar : PubMed/NCBI
6	Buckanovich RJ, Facciabene A, Kim S, et al: Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med. 14:28–36. 2008. View Article : Google Scholar : PubMed/NCBI
7	Nelson JB, Fizazi K, Miller K, et al: Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone. Cancer. 118:5709–5718. 2012. View Article : Google Scholar : PubMed/NCBI
8	Miller K, Moul JW, Gleave M, et al: Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 16:187–192. 2013.PubMed/NCBI
9	Clézardin P: Therapeutic targets for bone metastases in breast cancer. Breast Cancer Res. 13:2072011.
10	Asundi J, Reed C, Arca J, et al: An antibody-drug conjugate targeting the endothelin B receptor for the treatment of melanoma. Clin Cancer Res. 17:965–975. 2011. View Article : Google Scholar : PubMed/NCBI
11	Cruz-Muñoz W, Jaramillo ML, Man S, et al: Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma. Cancer Res. 72:4909–4919. 2012.PubMed/NCBI
12	Liu Y, Ye F, Yamada K, et al: Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells. Mol Cancer Res. 9:1668–1685. 2011. View Article : Google Scholar : PubMed/NCBI
13	Knight LJ, Burrage J, Bujac SR, et al: Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer. Int J Oncol. 34:465–471. 2009.PubMed/NCBI
14	Puglisi MA, Barba M, Corbi M, et al: Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells. J Pathol. 225:305–314. 2011.PubMed/NCBI
15	Sørby LA, Kleiveland CR, Andersen SN, Bukholm IR and Jacobsen MB: The endothelin axis in the metastatic process of colon carcinoma. Anticancer Res. 31:861–869. 2011.PubMed/NCBI
16	Wang R, Löhr CV, Fischer K, et al: Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer. Int J Cancer. 132:1004–1012. 2013. View Article : Google Scholar : PubMed/NCBI
17	Tao K, Wu C, Wu K, et al: Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer. Med Oncol. 29:107–112. 2012. View Article : Google Scholar : PubMed/NCBI
18	Ishimoto S, Wada K, Tanaka N, et al: Role of endothelin receptor signalling in squamous cell carcinoma. Int J Oncol. 40:1011–1019. 2012.PubMed/NCBI
19	Hase R, Miyamoto M, Uehara H, et al: Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin Cancer Res. 11:8737–8744. 2005. View Article : Google Scholar : PubMed/NCBI
20	Evans NJ and Walker JW: Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J. 95:483–492. 2008. View Article : Google Scholar : PubMed/NCBI
21	Klammt C, Srivastava A, Eifler N, et al: Functional analysis of cell-free-produced human endothelin B receptor reveals transmembrane segment 1 as an essential area for ET-1 binding and homodimer formation. FEBS J. 274:3257–3269. 2007. View Article : Google Scholar
22	Elshourbagy NA, Adamou JE, Gagnon AW, Wu HL, Pullen M and Nambi P: Molecular characterization of a novel human endothelin receptor splice variant. J Biol Chem. 271:25300–25307. 1996. View Article : Google Scholar : PubMed/NCBI
23	Shyamala V, Moulthrop TH, Stratton-Thomas J and Tekamp-Olson P: Two distinct human endothelin B receptors generated by alternative splicing from a single gene. Cell Mol Biol Res. 40:285–296. 1994.PubMed/NCBI